CHORIONIC GONADOTROPIN

CHORIONIC GONADOTROPIN was reported 561 times

CHORIONIC GONADOTROPIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD HUMAN CHORIONIC GONADOTROPIN NEGATIVE 1 0.5000
1 OVARIAN TORSION 18 0.2169
2 LUTEINISING UNRUPTURED FOLLICLE SYNDROME 1 0.2000
3 MALIGNANT HYDATIDIFORM MOLE 1 0.1667
4 URINE DELTA AMINOLEVULINATE 1 0.1429
5 FEMALE GENITAL TRACT TUBERCULOSIS 1 0.1429
6 HETEROTOPIC PREGNANCY 7 0.1111
7 OVARIAN NECROSIS 7 0.1111
8 VARIANT CREUTZFELDT-JAKOB DISEASE 1 0.1111
9 THERMOPHOBIA 2 0.1053
10 CYSTOSARCOMA PHYLLODES 1 0.1000
11 GONADOTROPHIN DEFICIENCY 2 0.0741
12 BRAIN TERATOMA 1 0.0714
13 MULTIPLE PREGNANCY 10 0.0559
14 OVARIAN HYPERSTIMULATION SYNDROME 130 0.0557
15 OVARIAN HAEMATOMA 1 0.0556
16 SEX CHROMOSOME ABNORMALITY 1 0.0476
17 THROMBIN-ANTITHROMBIN III COMPLEX INCREASED 1 0.0476
18 PORPHYRINS URINE INCREASED 1 0.0476
19 OPTIC NERVE SHEATH MENINGIOMA 1 0.0455
20 URINE PORPHOBILINOGEN INCREASED 1 0.0455
21 YERSINIA TEST POSITIVE 1 0.0435
22 BLOOD PRESSURE SYSTOLIC INSPIRATORY DECREASED 2 0.0426
23 PRADER-WILLI SYNDROME 2 0.0392
24 BLOOD HUMAN CHORIONIC GONADOTROPIN DECREASED 1 0.0357
25 OVARIAN RUPTURE 4 0.0342
26 OVARIAN CYST TORSION 2 0.0339
27 HYDROSALPINX 3 0.0326
28 PERITONEAL HERNIA 1 0.0323
29 VENA CAVA FILTER REMOVAL 1 0.0294
30 OVARIAN ENLARGEMENT 11 0.0287
31 GLIOSARCOMA 1 0.0286
32 PERCUSSION TEST ABNORMAL 1 0.0270
33 OBSTETRIC PROCEDURE COMPLICATION 1 0.0270
34 ABORTION COMPLETE 1 0.0270
35 FLAP NECROSIS 1 0.0270
36 ABORTION SPONTANEOUS COMPLETE 1 0.0256
37 ABORTED PREGNANCY 1 0.0213
38 HIP SWELLING 1 0.0208
39 HEPATOBLASTOMA 2 0.0206
40 TUBAL RUPTURE 1 0.0200
41 CIRCULATORY FAILURE NEONATAL 1 0.0169
42 OVARIAN HAEMORRHAGE 4 0.0169
43 SEPTUM PELLUCIDUM AGENESIS 1 0.0167
44 CEREBRAL DYSGENESIS 1 0.0167
45 DUODENAL ATRESIA 2 0.0163
46 CEPHALO-PELVIC DISPROPORTION 3 0.0150
47 BORDERLINE OVARIAN TUMOUR 1 0.0149
48 NONINFECTIVE OOPHORITIS 1 0.0149
49 GARDNERELLA INFECTION 1 0.0145
50 NEONATAL RESPIRATORY ARREST 2 0.0137
51 OLIGODIPSIA 3 0.0128
52 INTRAPARTUM HAEMORRHAGE 1 0.0125
53 DRUG EXPOSURE BEFORE PREGNANCY 12 0.0118
54 UTERINE TENDERNESS 1 0.0116
55 HAEMOCONCENTRATION 2 0.0116
56 BREECH DELIVERY 1 0.0109
57 TWIN PREGNANCY 9 0.0107
58 EXCESSIVE EXERCISE 1 0.0105
59 CONJOINED TWINS 1 0.0101
60 ECTOPIC PREGNANCY 31 0.0101
61 ABORTION THREATENED 5 0.0100
62 OLIGOSPERMIA 1 0.0097
63 ANOVULATORY CYCLE 2 0.0097
64 PERIANAL ABSCESS 1 0.0096
65 PROGESTERONE INCREASED 1 0.0090
66 URETERIC INJURY 1 0.0089
67 CHLAMYDIA TEST POSITIVE 1 0.0088
68 OVULATION DISORDER 1 0.0085
69 UTERINE HYPOTONUS 1 0.0079
70 BLIGHTED OVUM 3 0.0076
71 RETINITIS PIGMENTOSA 2 0.0076
72 INTESTINAL MALROTATION 2 0.0076
73 BREAKTHROUGH HAEMOLYSIS 3 0.0075
74 UNWANTED PREGNANCY 1 0.0073
75 APPLICATION SITE NODULE 1 0.0073
76 MALIGNANT NEOPLASM OF AMPULLA OF VATER 1 0.0072
77 DISSEMINATED COCCIDIOIDOMYCOSIS 1 0.0071
78 HAEMORRHAGIC OVARIAN CYST 4 0.0070
79 CREUTZFELDT-JAKOB DISEASE 2 0.0069
80 RENAL ARTERY THROMBOSIS 2 0.0065
81 CHROMOSOMAL DELETION 1 0.0063
82 SALPINGITIS 2 0.0063
83 INTESTINAL STRANGULATION 1 0.0062
84 BASILAR ARTERY OCCLUSION 1 0.0060
85 CRANIOPHARYNGIOMA 2 0.0060
86 SELECTIVE ABORTION 1 0.0057
87 PELVIC FLUID COLLECTION 4 0.0057
88 BASILAR ARTERY THROMBOSIS 1 0.0056
89 RUPTURED ECTOPIC PREGNANCY 4 0.0052
90 PERITONEAL HAEMORRHAGE 7 0.0050
91 PRODUCT CONTAMINATION WITH BODY FLUID 1 0.0049
92 RETAINED PRODUCTS OF CONCEPTION 1 0.0049
93 SITTING DISABILITY 3 0.0049
94 GLUCOCORTICOID DEFICIENCY 2 0.0047
95 PLACENTA ACCRETA 1 0.0046
96 ALANINE AMINOTRANSFERASE 1 0.0045
97 THROMBOSIS MESENTERIC VESSEL 1 0.0044
98 RENAL CORTICAL NECROSIS 1 0.0043
99 MYELOPROLIFERATIVE DISORDER 1 0.0041
100 BLOOD LUTEINISING HORMONE INCREASED 1 0.0041
101 BUDD-CHIARI SYNDROME 1 0.0040
102 NEONATAL RESPIRATORY FAILURE 2 0.0040
103 CONGENITAL HYDROCEPHALUS 2 0.0039
104 THERAPEUTIC PRODUCT CONTAMINATION 1 0.0039
105 CEREBRAL CALCIFICATION 1 0.0037
106 ANTITHROMBIN III DECREASED 1 0.0037
107 PSEUDOLYMPHOMA 2 0.0036
108 CAROTID ARTERY THROMBOSIS 3 0.0035
109 SPLENIC HAEMATOMA 1 0.0035
110 HAEMORRHAGIC ASCITES 1 0.0035
111 CARDIO-RESPIRATORY DISTRESS 1 0.0035
112 FIBRIN DEGRADATION PRODUCTS INCREASED 1 0.0034
113 OESTRADIOL INCREASED 1 0.0033
114 SEMEN DISCOLOURATION 1 0.0033
115 INFREQUENT BOWEL MOVEMENTS 8 0.0032
116 OESOPHAGEAL ATRESIA 2 0.0032
117 FOETAL CARDIAC DISORDER 1 0.0032
118 ANOMALY OF EXTERNAL EAR CONGENITAL 1 0.0032
119 ADNEXAL TORSION 1 0.0032
120 ABORTION MISSED 4 0.0031
121 OESTRADIOL DECREASED 1 0.0031
122 TYMPANIC MEMBRANE DISORDER 1 0.0031
123 NEONATAL RESPIRATORY DEPRESSION 1 0.0030
124 VASCULAR STENOSIS 1 0.0029
125 NEONATAL INFECTION 1 0.0029
126 ACUTE DISSEMINATED ENCEPHALOMYELITIS 1 0.0029
127 CERVIX DISORDER 2 0.0028
128 SINGLE UMBILICAL ARTERY 1 0.0027
129 AXILLARY VEIN THROMBOSIS 1 0.0027
130 HYPEREMESIS GRAVIDARUM 1 0.0026
131 PRODUCT BARCODE ISSUE 1 0.0026
132 INFERTILITY FEMALE 4 0.0026
133 PLACENTA PRAEVIA 2 0.0025
134 VULVAL OEDEMA 1 0.0025
135 INTRA-UTERINE DEATH 4 0.0025
136 HYDROTHORAX 2 0.0024
137 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
138 AMAUROSIS 2 0.0024
139 MELANOMA RECURRENT 1 0.0024
140 ABDOMINAL CAVITY DRAINAGE 1 0.0024
141 PYLORIC STENOSIS 2 0.0024
142 OVARIAN CYST RUPTURED 3 0.0023
143 THREATENED LABOUR 1 0.0023
144 HALLUCINATION, OLFACTORY 1 0.0023
145 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 2 0.0023
146 CONGENITAL MUSCULOSKELETAL ANOMALY 1 0.0023
147 JUGULAR VEIN THROMBOSIS 4 0.0022
148 PELVIC INFECTION 1 0.0022
149 PREGNANCY TEST FALSE POSITIVE 1 0.0021
150 NEUROLOGICAL EXAMINATION ABNORMAL 1 0.0021
151 BASEDOW'S DISEASE 1 0.0021
152 PREMATURE RUPTURE OF MEMBRANES 5 0.0021
153 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 1 0.0021
154 DRAINAGE 1 0.0020
155 HYPOGONADISM 2 0.0020
156 CERVICAL INCOMPETENCE 1 0.0020
157 CEREBRAL ARTERY THROMBOSIS 1 0.0019
158 UTERINE CONTRACTIONS DURING PREGNANCY 2 0.0019
159 POLYCYSTIC OVARIES 3 0.0019
160 FEEDING DISORDER NEONATAL 2 0.0019
161 TRANSVERSE SINUS THROMBOSIS 1 0.0019
162 TUMOUR NECROSIS 2 0.0019
163 GINGIVAL DISCOLOURATION 1 0.0019
164 MORNING SICKNESS 1 0.0018
165 THROMBOCYTHAEMIA 1 0.0018
166 BLOOD GROWTH HORMONE INCREASED 1 0.0018
167 PORTAL HYPERTENSIVE GASTROPATHY 1 0.0018
168 HAEMATOCRIT INCREASED 4 0.0018
169 EJECTION FRACTION 1 0.0017
170 BLOOD OESTROGEN INCREASED 1 0.0017
171 OXYGEN CONSUMPTION DECREASED 1 0.0017
172 CAESAREAN SECTION 19 0.0016
173 BLOOD OSMOLARITY DECREASED 1 0.0016
174 BREECH PRESENTATION 2 0.0016
175 HYPOPROTEINAEMIA 3 0.0016
176 HYPERCOAGULATION 3 0.0016
177 PANCREATIC NEUROENDOCRINE TUMOUR 1 0.0016
178 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 1 0.0015
179 EFFUSION 2 0.0015
180 SURGICAL PROCEDURE REPEATED 1 0.0015
181 HAEMORRHAGIC CEREBRAL INFARCTION 1 0.0014
182 MULTIPLE CONGENITAL ABNORMALITIES 2 0.0014
183 INFUSION SITE BRUISING 3 0.0014
184 RENAL INFARCT 2 0.0014
185 WITHDRAWAL BLEED 1 0.0014
186 LEGAL PROBLEM 1 0.0014
187 CEREBRAL VASOCONSTRICTION 1 0.0014
188 COMPLICATION OF PREGNANCY 1 0.0013
189 OVARIAN NEOPLASM 1 0.0013
190 PULMONARY ARTERY THROMBOSIS 1 0.0013
191 BLOOD FIBRINOGEN INCREASED 1 0.0013
192 RETROGRADE EJACULATION 1 0.0013
193 INTRA-ABDOMINAL HAEMORRHAGE 3 0.0013
194 SUPERIOR SAGITTAL SINUS THROMBOSIS 1 0.0013
195 CONGENITAL CYSTIC KIDNEY DISEASE 1 0.0012
196 CORONARY ARTERY DISSECTION 1 0.0012
197 EOSINOPHILIC PNEUMONIA ACUTE 1 0.0012
198 HYPOPITUITARISM 2 0.0011
199 TESTICULAR ATROPHY 1 0.0011
200 HUMAN CHORIONIC GONADOTROPIN INCREASED 1 0.0011
201 DRUG EXPOSURE DURING PREGNANCY 37 0.0011
202 EXTENSOR PLANTAR RESPONSE 1 0.0011
203 HAEMOCHROMATOSIS 1 0.0011
204 OVARIAN DISORDER 1 0.0011
205 CEREBRAL THROMBOSIS 3 0.0011
206 ASCITES 31 0.0011
207 ABORTION 3 0.0010
208 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
209 HEMIANOPIA 1 0.0010
210 MESENTERIC VEIN THROMBOSIS 1 0.0010
211 THYROIDITIS 3 0.0010
212 BRAIN HYPOXIA 1 0.0010
213 AUTISM 1 0.0010
214 BODY TEMPERATURE FLUCTUATION 2 0.0010
215 HYPOPERFUSION 1 0.0010
216 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 2 0.0009
217 SMALL INTESTINAL STENOSIS 1 0.0009
218 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
219 CEREBRAL ARTERY OCCLUSION 1 0.0009
220 DRUG EXPOSURE VIA BREAST MILK 1 0.0009
221 BIPOLAR I DISORDER 2 0.0009
222 CRYPTORCHISM 1 0.0009
223 PREMATURE LABOUR 5 0.0009
224 OESTROGEN RECEPTOR ASSAY POSITIVE 1 0.0009
225 LIGAMENT INJURY 1 0.0009
226 MATERNAL EXPOSURE BEFORE PREGNANCY 6 0.0009
227 ARTERIAL HAEMORRHAGE 1 0.0009
228 CEREBRAL VENTRICLE DILATATION 1 0.0009
229 ABORTION INDUCED 8 0.0008
230 PREGNANCY 17 0.0008
231 STREPTOCOCCAL SEPSIS 1 0.0008
232 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
233 ENCEPHALITIS VIRAL 1 0.0008
234 CEREBRAL ARTERY EMBOLISM 1 0.0008
235 OLIGURIA 5 0.0008
236 TRISOMY 21 1 0.0008
237 RETINAL ARTERY OCCLUSION 2 0.0008
238 NECROTISING COLITIS 1 0.0008
239 MATERNAL DRUGS AFFECTING FOETUS 6 0.0008
240 ADNEXA UTERI PAIN 1 0.0008
241 MICROCEPHALY 1 0.0008
242 APGAR SCORE LOW 1 0.0008
243 IATROGENIC INJURY 1 0.0008
244 RETINAL DISORDER 2 0.0008
245 EXPOSURE VIA FATHER 1 0.0008
246 PATENT DUCTUS ARTERIOSUS 3 0.0008
247 DEATH NEONATAL 1 0.0007
248 MYELITIS TRANSVERSE 1 0.0007
249 INSULIN-LIKE GROWTH FACTOR INCREASED 1 0.0007
250 PELVIC VENOUS THROMBOSIS 1 0.0007
251 PORPHYRIA ACUTE 1 0.0007
252 INVESTIGATION ABNORMAL 1 0.0007
253 ESCHERICHIA SEPSIS 2 0.0007
254 MUTISM 1 0.0007
255 ACUTE ABDOMEN 1 0.0007
256 BRAIN HERNIATION 2 0.0007
257 HAEMORRHAGIC TRANSFORMATION STROKE 1 0.0007
258 ADHESION 1 0.0007
259 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
260 HYPOTONIA NEONATAL 1 0.0006
261 TESTICULAR PAIN 2 0.0006
262 HYPOVOLAEMIC SHOCK 3 0.0006
263 COLON CANCER METASTATIC 1 0.0006
264 POOR QUALITY DRUG ADMINISTERED 4 0.0006
265 OPTIC ATROPHY 1 0.0006
266 INJECTION RELATED REACTION 1 0.0006
267 SMALL FOR DATES BABY 3 0.0006
268 GAZE PALSY 1 0.0006
269 BLOOD CHLORIDE INCREASED 1 0.0006
270 PUPIL FIXED 1 0.0006
271 ABORTION SPONTANEOUS 23 0.0006
272 CEREBRAL VENOUS THROMBOSIS 1 0.0006
273 VULVOVAGINAL SWELLING 1 0.0005
274 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
275 PUPILLARY REFLEX IMPAIRED 1 0.0005
276 INTRACRANIAL PRESSURE INCREASED 3 0.0005
277 ABORTION INCOMPLETE 1 0.0005
278 PROTEIN TOTAL DECREASED 2 0.0005
279 ARTERIAL THROMBOSIS 1 0.0005
280 HYPERTRIGLYCERIDAEMIA 3 0.0005
281 VENOUS THROMBOSIS 2 0.0005
282 OVARIAN CYST 5 0.0005
283 RENAL HAEMORRHAGE 1 0.0005
284 QUADRIPLEGIA 1 0.0005
285 INTESTINAL STENOSIS 2 0.0005
286 OPTIC NEUROPATHY 1 0.0005
287 LYMPHOCYTOSIS 1 0.0005
288 SPINAL COLUMN INJURY 1 0.0004
289 INFECTIOUS MONONUCLEOSIS 1 0.0004
290 HAEMOGLOBIN INCREASED 2 0.0004
291 UTERINE DISORDER 1 0.0004
292 COLITIS MICROSCOPIC 2 0.0004
293 CARDIAC TAMPONADE 2 0.0004
294 VARICELLA 1 0.0004
295 GASTROINTESTINAL OBSTRUCTION 1 0.0004
296 PAINFUL RESPIRATION 1 0.0004
297 LYMPHADENITIS 1 0.0004
298 BREATH SOUNDS ABNORMAL 2 0.0004
299 BREAST TENDERNESS 3 0.0004
300 PLEURAL EFFUSION 24 0.0004
301 HOSTILITY 1 0.0004
302 LACTOSE INTOLERANCE 1 0.0004
303 DISSEMINATED TUBERCULOSIS 1 0.0004
304 HAEMOLYSIS 3 0.0004
305 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
306 ANGIONEUROTIC OEDEMA 1 0.0004
307 AREFLEXIA 1 0.0004
308 ABDOMINAL RIGIDITY 1 0.0004
309 HYDROCEPHALUS 2 0.0004
310 RED BLOOD CELL COUNT INCREASED 1 0.0004
311 INFUSION SITE ERYTHEMA 3 0.0004
312 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
313 GENERALISED ERYTHEMA 2 0.0004
314 VISUAL DISTURBANCE 2 0.0003
315 RETINAL VEIN OCCLUSION 1 0.0003
316 METABOLIC DISORDER 2 0.0003
317 URINE OUTPUT DECREASED 3 0.0003
318 PURPURA 3 0.0003
319 CEREBROVASCULAR DISORDER 1 0.0003
320 VARICES OESOPHAGEAL 1 0.0003
321 PELVIC PAIN 6 0.0003
322 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
323 GENITAL HAEMORRHAGE 4 0.0003
324 OEDEMA MOUTH 1 0.0003
325 BREAST ENLARGEMENT 1 0.0003
326 OTITIS MEDIA 1 0.0003
327 CYTOLYTIC HEPATITIS 1 0.0003
328 LYME DISEASE 1 0.0003
329 NEOPLASM RECURRENCE 1 0.0003
330 DIFFICULTY IN WALKING 1 0.0003
331 PRIAPISM 1 0.0003
332 MASS 4 0.0003
333 EMBOLIC STROKE 1 0.0003
334 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
335 VISUAL FIELD DEFECT 2 0.0003
336 VENTRICULAR ARRHYTHMIA 1 0.0003
337 HYPOMANIA 1 0.0003
338 PHARMACEUTICAL PRODUCT COMPLAINT 7 0.0003
339 PULMONARY MASS 4 0.0003
340 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
341 GINGIVAL DISORDER 1 0.0003
342 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
343 HYPOALBUMINAEMIA 2 0.0003
344 DIVERTICULITIS 7 0.0003
345 BLOOD ALBUMIN DECREASED 2 0.0003
346 LOW BIRTH WEIGHT BABY 2 0.0003
347 CANDIDIASIS 1 0.0002
348 CEREBRAL INFARCTION 6 0.0002
349 GOITRE 1 0.0002
350 ESCHERICHIA INFECTION 2 0.0002
351 PERITONITIS 5 0.0002
352 GASTROINTESTINAL PERFORATION 1 0.0002
353 ABDOMINAL DISTENSION 25 0.0002
354 POOR PERIPHERAL CIRCULATION 1 0.0002
355 PREMATURE BABY 7 0.0002
356 CHAPPED LIPS 1 0.0002
357 IMMUNE SYSTEM DISORDER 3 0.0002
358 PHYSICAL DISABILITY 1 0.0002
359 GRAND MAL CONVULSION 2 0.0002
360 LOCALISED OEDEMA 1 0.0002
361 LACERATION 2 0.0002
362 PRE-ECLAMPSIA 1 0.0002
363 GESTATIONAL DIABETES 1 0.0002
364 ENDOMETRIOSIS 1 0.0002
365 SUBCUTANEOUS ABSCESS 1 0.0002
366 TUMOUR MARKER INCREASED 1 0.0002
367 AFFECT LABILITY 2 0.0002
368 HYPERTHYROIDISM 3 0.0002
369 STILLBIRTH 1 0.0002
370 ENTEROCOCCAL INFECTION 1 0.0002
371 GUILLAIN-BARRE SYNDROME 1 0.0002
372 RENAL CELL CARCINOMA 1 0.0002
373 HYPOTONIA 2 0.0002
374 KLEBSIELLA INFECTION 1 0.0002
375 DYSLIPIDAEMIA 1 0.0002
376 SUBARACHNOID HAEMORRHAGE 2 0.0002
377 THYROID DISORDER 3 0.0002
378 CEREBRAL ISCHAEMIA 1 0.0002
379 VARICOSE VEIN 1 0.0002
380 FOETAL DEATH 1 0.0002
381 PERIORBITAL OEDEMA 1 0.0002
382 PETECHIAE 2 0.0002
383 UNINTENDED PREGNANCY 2 0.0002
384 CATATONIA 1 0.0002
385 SENSITIVITY TO WEATHER CHANGE 1 0.0002
386 SERUM FERRITIN INCREASED 1 0.0002
387 NYSTAGMUS 1 0.0002
388 COMPRESSION FRACTURE 1 0.0002
389 DRUG EFFECT DECREASED 10 0.0002
390 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
391 MANIA 3 0.0002
392 NECROSIS 1 0.0002
393 FEELING COLD 5 0.0002
394 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
395 ACUTE PULMONARY OEDEMA 1 0.0002
396 CIRCULATORY COLLAPSE 3 0.0002
397 IMPAIRED DRIVING ABILITY 2 0.0002
398 NEUROLOGICAL SYMPTOM 1 0.0002
399 SKIN WARM 1 0.0002
400 PRODUCT LABEL CONFUSION 1 0.0002
401 SPLENOMEGALY 2 0.0002
402 URINE ODOUR ABNORMAL 1 0.0002
403 BACTERAEMIA 2 0.0002
404 PROTHROMBIN TIME PROLONGED 1 0.0002
405 TENSION 1 0.0002
406 DRUG ABUSER 1 0.0002
407 DRUG DIVERSION 1 0.0002
408 VAGINAL HAEMORRHAGE 7 0.0002
409 PRE-EXISTING CONDITION IMPROVED 1 0.0002
410 BLOOD SODIUM DECREASED 3 0.0002
411 BRAIN OEDEMA 2 0.0002
412 MUSCLE ATROPHY 2 0.0002
413 INJECTION SITE IRRITATION 2 0.0002
414 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
415 MYDRIASIS 2 0.0002
416 UNRESPONSIVE TO STIMULI 4 0.0002
417 BREAST CANCER STAGE III 1 0.0002
418 DEEP VEIN THROMBOSIS 10 0.0002
419 PRODUCT PREPARATION ISSUE 1 0.0002
420 HAEMATOCRIT DECREASED 3 0.0002
421 POST-TRAUMATIC STRESS DISORDER 1 0.0001
422 JAUNDICE 4 0.0001
423 METASTASES TO LYMPH NODES 1 0.0001
424 UVEITIS 2 0.0001
425 TACHYPNOEA 2 0.0001
426 PALLOR 4 0.0001
427 FEELING HOT 9 0.0001
428 BLOOD TESTOSTERONE DECREASED 1 0.0001
429 NEPHROTIC SYNDROME 1 0.0001
430 METASTASIS 1 0.0001
431 TONGUE DISORDER 1 0.0001
432 INTENTIONAL UNDERDOSE 1 0.0001
433 ORAL DISORDER 1 0.0001
434 DUODENAL ULCER PERFORATION 1 0.0001
435 PANCREATITIS ACUTE 3 0.0001
436 PAROSMIA 1 0.0001
437 HYPERTHERMIA 1 0.0001
438 PERICARDIAL EFFUSION 3 0.0001
439 EMOTIONAL DISORDER 4 0.0001
440 CONGENITAL ANOMALY 1 0.0001
441 THERAPY PARTIAL RESPONDER 2 0.0001
442 BASAL CELL CARCINOMA 2 0.0001
443 PULMONARY HAEMORRHAGE 1 0.0001
444 PULMONARY EMBOLISM 12 0.0001
445 FURUNCLE 1 0.0001
446 PREMATURE DELIVERY 2 0.0001
447 BLOOD DISORDER 1 0.0001
448 ABNORMAL FAECES 1 0.0001
449 HAIR DISORDER 1 0.0001
450 MENSTRUAL DISORDER 1 0.0001
451 MUSCLE INJURY 1 0.0001
452 EMBOLISM 1 0.0001
453 HEMIPLEGIA 1 0.0001
454 BREAST CANCER STAGE II 1 0.0001
455 LIVE BIRTH 1 0.0001
456 HAEMODIALYSIS 1 0.0001
457 ABDOMINAL PAIN LOWER 3 0.0001
458 INADEQUATE ANALGESIA 1 0.0001
459 PRODUCT CONTAINER ISSUE 1 0.0001
460 INFLAMMATION 6 0.0001
461 GROIN PAIN 1 0.0001
462 LYMPHADENOPATHY 4 0.0001
463 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
464 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
465 BLOOD BILIRUBIN INCREASED 3 0.0001
466 CRYING 4 0.0001
467 OPTIC NEURITIS 1 0.0001
468 PATHOGEN RESISTANCE 1 0.0001
469 OVARIAN CANCER 1 0.0001
470 APPENDICITIS 1 0.0001
471 FLANK PAIN 1 0.0001
472 HYPONATRAEMIA 6 0.0001
473 LEUKAEMIA 1 0.0001
474 COMA 5 0.0001
475 POST PROCEDURAL COMPLICATION 2 0.0001
476 ACUTE RESPIRATORY FAILURE 2 0.0001
477 DIZZINESS POSTURAL 1 0.0001
478 PHARYNGEAL SWELLING 1 0.0001
479 HEPATOMEGALY 1 0.0001
480 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
481 SALIVARY HYPERSECRETION 1 0.0001
482 SPINAL FRACTURE 2 0.0001
483 THROMBOSIS 8 0.0001
484 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
485 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
486 PRODUCT PREPARATION ERROR 2 0.0001
487 HYPERBILIRUBINAEMIA 1 0.0001
488 TENDERNESS 1 0.0001
489 WEIGHT FLUCTUATION 1 0.0001
490 DECREASED ACTIVITY 1 0.0001
491 ABDOMINAL PAIN 21 0.0001
492 NERVE INJURY 1 0.0001
493 METASTASES TO LUNG 1 0.0001
494 ELECTROLYTE IMBALANCE 1 0.0001
495 FIBROMYALGIA 2 0.0001
496 NEURALGIA 2 0.0001
497 HYPERCALCAEMIA 1 0.0001
498 GENERALISED OEDEMA 1 0.0001
499 HAEMOGLOBIN DECREASED 8 0.0001
500 HIATUS HERNIA 1 0.0001
501 RESPIRATORY TRACT INFECTION 2 0.0001
502 PLATELET COUNT INCREASED 1 0.0001
503 ADVERSE REACTION 1 0.0001
504 QUALITY OF LIFE DECREASED 1 0.0001
505 DISTURBANCE IN ATTENTION 4 0.0001
506 GINGIVAL BLEEDING 1 0.0001
507 CORONARY ARTERY OCCLUSION 1 0.0001
508 PERIPHERAL COLDNESS 1 0.0001
509 RESPIRATORY ARREST 2 0.0001
510 HUNGER 1 0.0001
511 CARDIO-RESPIRATORY ARREST 3 0.0001
512 BLOOD TEST ABNORMAL 1 0.0001
513 SINUS TACHYCARDIA 1 0.0001
514 BRONCHOSPASM 1 0.0001
515 PARALYSIS 1 0.0001
516 CARDIOGENIC SHOCK 1 0.0001
517 IMPAIRED QUALITY OF LIFE 1 0.0001
518 RESPIRATORY FAILURE 5 0.0001
519 APATHY 1 0.0001
520 RESPIRATORY DISORDER 2 0.0001
521 HYPOAESTHESIA ORAL 1 0.0001
522 DRUG DISPENSING ERROR 1 0.0001
523 INSURANCE ISSUE 1 0.0001
524 NERVOUS SYSTEM DISORDER 2 0.0001
525 MENINGIOMA 1 0.0001
526 CYANOSIS 1 0.0001
527 RESPIRATORY TRACT CONGESTION 1 0.0001
528 BLOOD POTASSIUM INCREASED 1 0.0001
529 VENTRICULAR TACHYCARDIA 1 0.0001
530 FUNGAL INFECTION 2 0.0001
531 URINARY RETENTION 2 0.0001
532 BLOOD UREA INCREASED 1 0.0001
533 FACE OEDEMA 1 0.0001
534 METRORRHAGIA 1 0.0001
535 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
536 MULTI-ORGAN FAILURE 1 0.0001
537 DELIRIUM 2 0.0001
538 METASTASES TO LIVER 1 0.0001
539 PANCREATITIS 3 0.0001
540 BRADYCARDIA 3 0.0001
541 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
542 GALLBLADDER DISORDER 1 0.0001
543 LEUKOCYTOSIS 1 0.0001
544 HYPERGLYCAEMIA 2 0.0001
545 OROPHARYNGEAL PAIN 5 0.0001
546 NECK PAIN 3 0.0001
547 SWELLING 5 0.0001
548 DYSARTHRIA 2 0.0001
549 DEHYDRATION 7 0.0001
550 CONVULSION 3 0.0001
551 SLEEP APNOEA SYNDROME 1 0.0001
552 ACUTE KIDNEY INJURY 8 0.0001
553 LOWER LIMB FRACTURE 1 0.0001
554 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
555 ORAL HERPES 1 0.0001
556 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
557 ABNORMAL BEHAVIOUR 2 0.0001
558 BLOOD PRESSURE ABNORMAL 1 0.0001
559 PRODUCT PHYSICAL ISSUE 1 0.0000
560 PSORIATIC ARTHROPATHY 2 0.0000
561 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
562 BODY TEMPERATURE INCREASED 1 0.0000
563 RIB FRACTURE 1 0.0000
564 RHABDOMYOLYSIS 2 0.0000
565 POLLAKIURIA 2 0.0000
566 DYSPNOEA 27 0.0000
567 DECREASED APPETITE 11 0.0000
568 ANAEMIA 9 0.0000
569 OSTEOARTHRITIS 2 0.0000
570 RENAL FAILURE ACUTE 2 0.0000
571 IMPAIRED WORK ABILITY 1 0.0000
572 HYPERHIDROSIS 6 0.0000
573 PRODUCT DISPENSING ERROR 1 0.0000
574 PRODUCT PRESCRIBING ISSUE 1 0.0000
575 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
576 TACHYCARDIA 4 0.0000
577 STEVENS-JOHNSON SYNDROME 1 0.0000
578 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
579 CHROMATURIA 1 0.0000
580 APPLICATION SITE PRURITUS 1 0.0000
581 ERYTHEMA 9 0.0000
582 SHOCK 1 0.0000
583 RENAL DISORDER 2 0.0000
584 ARRHYTHMIA 2 0.0000
585 PRODUCT PRESCRIBING ERROR 1 0.0000
586 PRODUCTIVE COUGH 2 0.0000
587 HEADACHE 26 0.0000
588 OEDEMA PERIPHERAL 5 0.0000
589 AGITATION 3 0.0000
590 ENCEPHALOPATHY 1 0.0000
591 ABASIA 1 0.0000
592 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
593 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
594 CARDIOVASCULAR DISORDER 1 0.0000
595 FLUSHING 4 0.0000
596 HEPATITIS 1 0.0000
597 PAIN 24 0.0000
598 LOSS OF CONSCIOUSNESS 5 0.0000
599 ERECTILE DYSFUNCTION 1 0.0000
600 ANAPHYLACTIC SHOCK 1 0.0000
601 BACK PAIN 9 0.0000
602 OFF LABEL USE 33 0.0000
603 EAR INFECTION 1 0.0000
604 INSOMNIA 10 0.0000
605 BREAST CANCER FEMALE 1 0.0000
606 MENSTRUATION IRREGULAR 1 0.0000
607 PRODUCT USE ISSUE 7 0.0000
608 INFLUENZA LIKE ILLNESS 3 0.0000
609 RESPIRATORY DISTRESS 1 0.0000
610 HAEMOPTYSIS 1 0.0000
611 DEMENTIA 1 0.0000
612 WEIGHT INCREASED 8 0.0000
613 OXYGEN SATURATION DECREASED 2 0.0000
614 EYE PAIN 2 0.0000
615 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
616 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
617 HYPERSOMNIA 1 0.0000
618 SOMNOLENCE 7 0.0000
619 LETHARGY 2 0.0000
620 LIVER FUNCTION TEST ABNORMAL 1 0.0000
621 NAUSEA 27 0.0000
622 ACUTE MYOCARDIAL INFARCTION 1 0.0000
623 LABORATORY TEST ABNORMAL 1 0.0000
624 PSYCHOTIC DISORDER 1 0.0000
625 HEPATIC FAILURE 1 0.0000
626 EMOTIONAL DISTRESS 4 0.0000
627 SUICIDE ATTEMPT 2 0.0000
628 ILL-DEFINED DISORDER 2 0.0000
629 SWOLLEN TONGUE 1 0.0000
630 VOMITING 15 0.0000
631 MIGRAINE 3 0.0000
632 MOOD SWINGS 1 0.0000
633 HYPOTHYROIDISM 1 0.0000
634 PRURITUS 12 0.0000
635 INTENTIONAL OVERDOSE 2 0.0000
636 NIGHT SWEATS 1 0.0000
637 RHINORRHOEA 2 0.0000
638 CONFUSIONAL STATE 5 0.0000
639 DEPRESSION 7 0.0000
640 AMNESIA 2 0.0000
641 ALOPECIA 6 0.0000
642 DYSPEPSIA 3 0.0000
643 EYE DISORDER 1 0.0000
644 STAPHYLOCOCCAL INFECTION 1 0.0000
645 HEART RATE INCREASED 3 0.0000
646 INFUSION RELATED REACTION 2 0.0000
647 FEBRILE NEUTROPENIA 2 0.0000
648 VISUAL ACUITY REDUCED 1 0.0000
649 EXPIRED PRODUCT ADMINISTERED 1 0.0000
650 LIP SWELLING 1 0.0000
651 EYE PRURITUS 1 0.0000
652 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
653 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
654 ANGER 1 0.0000
655 CHEST DISCOMFORT 3 0.0000
656 HAEMATURIA 1 0.0000
657 PYREXIA 10 0.0000
658 DRUG INEFFECTIVE 38 0.0000
659 NEOPLASM PROGRESSION 1 0.0000
660 HAEMORRHAGE 3 0.0000
661 INJURY 2 0.0000
662 HYPOXIA 1 0.0000
663 SLEEP DISORDER 2 0.0000
664 ANXIETY 8 0.0000
665 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
666 C-REACTIVE PROTEIN INCREASED 1 0.0000
667 RESTLESSNESS 1 0.0000
668 DYSURIA 1 0.0000
669 DYSGEUSIA 2 0.0000
670 HYPOAESTHESIA 4 0.0000
671 ASTHENIA 10 0.0000
672 DYSPNOEA EXERTIONAL 1 0.0000
673 ASTHMA 3 0.0000
674 HOT FLUSH 2 0.0000
675 INTESTINAL OBSTRUCTION 1 0.0000
676 UNEVALUABLE EVENT 2 0.0000
677 CHRONIC KIDNEY DISEASE 2 0.0000
678 PLASMA CELL MYELOMA 1 0.0000
679 DISORIENTATION 1 0.0000
680 CARDIAC FAILURE 2 0.0000
681 TREATMENT FAILURE 2 0.0000
682 DRUG ABUSE 2 0.0000
683 URTICARIA 4 0.0000
684 MYALGIA 4 0.0000
685 CONDITION AGGRAVATED 7 0.0000
686 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
687 LIVER DISORDER 1 0.0000
688 PULMONARY OEDEMA 1 0.0000
689 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
690 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
691 THERAPY NON-RESPONDER 1 0.0000
692 NO ADVERSE EVENT 4 0.0000
693 INCORRECT DOSE ADMINISTERED 5 0.0000
694 VISION BLURRED 3 0.0000
695 MEMORY IMPAIRMENT 3 0.0000
696 SKIN DISCOLOURATION 1 0.0000
697 WEIGHT DECREASED 6 0.0000
698 DYSPHAGIA 2 0.0000
699 RASH ERYTHEMATOUS 1 0.0000
700 MULTIPLE SCLEROSIS 1 0.0000
701 FEELING ABNORMAL 5 0.0000
702 MALAISE 9 0.0000
703 DRY EYE 1 0.0000
704 AGGRESSION 1 0.0000
705 FLUID RETENTION 1 0.0000
706 PERIPHERAL SWELLING 3 0.0000
707 ABDOMINAL PAIN UPPER 4 0.0000
708 NERVOUSNESS 1 0.0000
709 DERMATITIS ATOPIC 1 0.0000
710 DEPRESSED MOOD 1 0.0000
711 PLATELET COUNT DECREASED 2 0.0000
712 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
713 ANAPHYLACTIC REACTION 1 0.0000
714 ARTHROPATHY 1 0.0000
715 MEDICATION ERROR 1 0.0000
716 FATIGUE 14 0.0000
717 ABDOMINAL DISCOMFORT 3 0.0000
718 CEREBROVASCULAR ACCIDENT 3 0.0000
719 FLATULENCE 1 0.0000
720 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
721 MYOCARDIAL INFARCTION 3 0.0000
722 DYSPHONIA 1 0.0000
723 BONE PAIN 1 0.0000
724 CHILLS 2 0.0000
725 IRRITABILITY 1 0.0000
726 THERAPEUTIC RESPONSE DECREASED 1 0.0000
727 VERTIGO 1 0.0000
728 NASOPHARYNGITIS 3 0.0000
729 CHEST PAIN 3 0.0000
730 HYPERSENSITIVITY 3 0.0000
731 EXPOSURE DURING PREGNANCY 1 0.0000
732 DIZZINESS 8 0.0000
733 PRODUCT DOSE OMISSION 1 0.0000
734 RENAL FAILURE 2 0.0000
735 BLOOD PRESSURE DECREASED 1 0.0000
736 DRY SKIN 2 0.0000
737 PRODUCT QUALITY ISSUE 2 0.0000
738 HEPATIC ENZYME INCREASED 1 0.0000
739 ARTHRALGIA 6 0.0000
740 BURNING SENSATION 1 0.0000
741 THERAPY INTERRUPTED 1 0.0000
742 MOBILITY DECREASED 1 0.0000
743 INJECTION SITE PAIN 4 0.0000
744 PARAESTHESIA 2 0.0000
745 INJECTION SITE BRUISING 1 0.0000
746 INJECTION SITE HAEMORRHAGE 1 0.0000
747 DRUG DEPENDENCE 2 0.0000
748 PROSTATE CANCER 1 0.0000
749 DRY MOUTH 1 0.0000
750 CARDIAC ARREST 1 0.0000
751 TREMOR 2 0.0000
752 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
753 TOXICITY TO VARIOUS AGENTS 2 0.0000
754 PRODUCT STORAGE ERROR 1 0.0000
755 INTENTIONAL PRODUCT MISUSE 1 0.0000
756 GASTROINTESTINAL DISORDER 1 0.0000
757 ADVERSE DRUG REACTION 1 0.0000
758 SUICIDAL IDEATION 1 0.0000
759 NEUROPATHY PERIPHERAL 1 0.0000
760 GAIT DISTURBANCE 2 0.0000
761 PAIN IN EXTREMITY 3 0.0000
762 SYNCOPE 1 0.0000
763 HYPOTENSION 2 0.0000
764 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
765 HYPERTENSION 2 0.0000
766 DEATH 8 0.0000
767 OVERDOSE 2 0.0000
768 CONSTIPATION 2 0.0000
769 FALL 3 0.0000
770 MUSCULAR WEAKNESS 1 0.0000
771 PALPITATIONS 1 0.0000
772 DISEASE PROGRESSION 1 0.0000
773 VISUAL IMPAIRMENT 1 0.0000
774 INJECTION SITE ERYTHEMA 1 0.0000
775 DIARRHOEA 5 0.0000
776 NEUTROPENIA 1 0.0000
777 COUGH 2 0.0000
778 INFECTION 1 0.0000
779 RASH 3 0.0000
780 BLOOD PRESSURE INCREASED 1 0.0000
781 HOSPITALISATION 1 0.0000
782 DRUG INTERACTION 1 0.0000
783 COVID-19 1 0.0000
784 MUSCLE SPASMS 1 0.0000
785 BLOOD GLUCOSE INCREASED 1 0.0000
786 PNEUMONIA 1 0.0000